Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214.

Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN, Li X, Berry DL, Kallakury BV, Chauhan SC, Collins SP, Suy S, Kumar D.

PLoS One. 2013 Oct 22;8(10):e76994. doi: 10.1371/journal.pone.0076994. eCollection 2013.

PMID:
24167554
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Circulatory miR-628-5p is downregulated in prostate cancer patients.

Srivastava A, Goldberger H, Dimtchev A, Marian C, Soldin O, Li X, Collins SP, Suy S, Kumar D.

Tumour Biol. 2014 May;35(5):4867-73. doi: 10.1007/s13277-014-1638-1. Epub 2014 Jan 30.

PMID:
24477576
[PubMed - indexed for MEDLINE]
3.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
[PubMed - indexed for MEDLINE]
4.

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

J Hum Genet. 2012 Nov 26;57(11):691-9. doi: 10.1038/jhg.2012.95. Epub 2012 Aug 2.

PMID:
22854542
[PubMed - indexed for MEDLINE]
5.

Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.

Schubert M, Spahn M, Kneitz S, Scholz CJ, Joniau S, Stroebel P, Riedmiller H, Kneitz B.

PLoS One. 2013 Jun 14;8(6):e65064. doi: 10.1371/journal.pone.0065064. Print 2013.

PMID:
23798998
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.

Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.

Int J Cancer. 2010 Mar 1;126(5):1166-76. doi: 10.1002/ijc.24827.

PMID:
19676045
[PubMed - indexed for MEDLINE]
7.

Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.

He HC, Han ZD, Dai QS, Ling XH, Fu X, Lin ZY, Deng YH, Qin GQ, Cai C, Chen JH, Jiang FN, Liu X, Zhong WD.

BMC Genomics. 2013 Nov 5;14:757. doi: 10.1186/1471-2164-14-757.

PMID:
24191917
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.

Erdmann K, Kaulke K, Thomae C, Huebner D, Sergon M, Froehner M, Wirth MP, Fuessel S.

BMC Cancer. 2014 Feb 11;14:82. doi: 10.1186/1471-2407-14-82.

PMID:
24517338
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.

Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M.

Am J Pathol. 2012 May;180(5):1808-15. doi: 10.1016/j.ajpath.2012.01.034. Epub 2012 Mar 15.

PMID:
22426337
[PubMed - indexed for MEDLINE]
Free Article
10.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725
[PubMed - indexed for MEDLINE]
11.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.

PMID:
20363096
[PubMed - indexed for MEDLINE]
12.

MicroRNAs associated with metastatic prostate cancer.

Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, Gout PW, Wang Y.

PLoS One. 2011;6(9):e24950. doi: 10.1371/journal.pone.0024950. Epub 2011 Sep 30.

PMID:
21980368
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.

Hagman Z, Larne O, Edsjö A, Bjartell A, Ehrnström RA, Ulmert D, Lilja H, Ceder Y.

Int J Cancer. 2010 Dec 15;127(12):2768-76. doi: 10.1002/ijc.25269.

PMID:
21351256
[PubMed - indexed for MEDLINE]
14.

Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.

Guzel E, Karatas OF, Semercioz A, Ekici S, Aykan S, Yentur S, Creighton CJ, Ittmann M, Ozen M.

Int J Cancer. 2014 Jun 28. doi: 10.1002/ijc.29054. [Epub ahead of print]

PMID:
24976077
[PubMed - as supplied by publisher]
15.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
[PubMed - indexed for MEDLINE]
16.

Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.

Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, Stathopoulos EN, Spandidos DA.

J Urol. 2012 Aug;188(2):615-23. doi: 10.1016/j.juro.2012.03.122. Epub 2012 Jun 15.

PMID:
22704449
[PubMed - indexed for MEDLINE]
17.

Identification of miR-30d as a novel prognostic maker of prostate cancer.

Kobayashi N, Uemura H, Nagahama K, Okudela K, Furuya M, Ino Y, Ito Y, Hirano H, Inayama Y, Aoki I, Nagashima Y, Kubota Y, Ishiguro H.

Oncotarget. 2012 Nov;3(11):1455-71.

PMID:
23231923
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.

Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.

Dis Markers. 2013;34(3):163-9. doi: 10.3233/DMA-120957.

PMID:
23334650
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Plasma miR-21: a potential diagnostic marker of colorectal cancer.

Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, Galandiuk S.

Ann Surg. 2012 Sep;256(3):544-51. doi: 10.1097/SLA.0b013e318265bd6f.

PMID:
22868372
[PubMed - indexed for MEDLINE]
20.

Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.

Shimizu T, Suzuki H, Nojima M, Kitamura H, Yamamoto E, Maruyama R, Ashida M, Hatahira T, Kai M, Masumori N, Tokino T, Imai K, Tsukamoto T, Toyota M.

Eur Urol. 2013 Jun;63(6):1091-100. doi: 10.1016/j.eururo.2012.11.030. Epub 2012 Nov 23.

PMID:
23200812
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk